1. Statement of the WHO Global Advisory Committee on Vaccine Safety (GACVS) COVID-19 subcommittee on reports of Guillain-Barré syndrome (GBS) following adenovirus vector COVID-19 vaccines. (2021). Accessed. August 5, 2021: https://www.who.int/news/item/26-07-2021-statement-of-the-who-gacvs-covid-19-subcommittee-on-gbs.
2. COVID-19 Vaccine Safety Update. VAXZEVRIA, AstraZeneca AB. European Medicines Agency, Amsterdam; 2021. https://www.ema.europa.eu/en/documents/covid-19-vaccine-safety-update/covid-19-vaccine-safety-update-vaxzevria-previo....
3. Recurrent Guillain-Barre syndrome following vaccination;Baxter R;Clin Infect Dis,2012
4. Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis;Salmon DA;Lancet,2013
5. Risk of Guillain-Barré syndrome following H1N1 influenza vaccination in Quebec;De Wals P;JAMA,2012